Patient characteristics, treatment patterns and early trends of lutetium Lu 177 vipivotide tetraxetan (177Lu-PSMA-617) use by US urologists and oncologists

被引:0
作者
Nguyen, Jennifer
Patel, Jeetvan
Kang, Barinder
Yu, Channing
Sawhney, Amrita
Fallick, Mark
Gorritz, Magdaliz
Chen, Chi-Chang
Paltanwale, Queenie
Sun, Kainan
Shore, Neal D.
机构
[1] Novartis Pharmaceut, E Hanover, NJ USA
[2] IQVIA Inc, Wayne, PA USA
[3] GenesisCare, Carolina Urol Res Ctr, Myrtle Beach, SC USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e17048
引用
收藏
页数:1
相关论文
empty
未找到相关数据